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Abstract
 
T cells recognize microbial glycolipids presented by CD1 proteins, but there is no information
regarding the generation of natural glycolipid antigens within infected tissues. Therefore, we
determined the molecular basis of CD1b-restricted T cell recognition of mycobacterial glyco-
sylated mycolates, including those produced during tissue infection in vivo. Transfection of the
 
T cell receptor (TCR) 
 
a
 
 and 
 
b
 
 chains from a glucose monomycolate (GMM)-specific T cell
line reconstituted GMM recognition in TCR-deficient T lymphoblastoma cells. This TCR-
 
mediated response was highly specific for natural mycobacterial glucose-6-
 
O
 
-(2
 
R
 
, 3
 
R
 
) mono-
mycolate, including the precise structure of the glucose moiety, the stereochemistry of the my-
colate lipid, and the linkage between the carbohydrate and the lipid. Mycobacterial production
of antigenic GMM absolutely required a nonmycobacterial source of glucose that could be sup-
plied by adding glucose to media at concentrations found in mammalian tissues or by infecting
tissue in vivo. These results indicate that mycobacteria synthesized antigenic GMM by cou-
pling mycobacterial mycolates to host-derived glucose. Specific T cell recognition of an
epitope formed by interaction of host and pathogen biosynthetic pathways provides a mecha-
nism for immune response to those pathogenic mycobacteria that have productively infected
tissues, as distinguished from ubiquitous, but innocuous, environmental mycobacteria.
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Introduction
 
In contrast to saprophytic mycobacteria that grow ubiqui-
tously in the environment, pathogenic mycobacteria cause
disease by crossing epithelia and growing within tissues.
Once mycobacteria successfully invade host tissues, extra-
cellular mycobacteria are generally cleared rapidly by mac-
rophages. Pathogenic mycobacteria persist long term
within host tissues, likely within infected phagosomes of
host macrophages (1, 2). Intracellular growth and persis-
tence account for the ability of mycobacteria to produce
chronic diseases such as leprosy and tuberculosis as well as
reactivation tuberculosis in the setting of malnutrition, ag-
ing, or acquired immunodeficiency. Cellular immunity to
mycobacteria is crucial to the successful host response to
infection, and antigen-specific Th1 T cells that activate
cell-mediated immunity by IFN-
 
g
 
 production have been
experimentally proven to mediate mycobacterial clearance
in infected animals (3–6). Most studies of T cell activation
by mycobacteria have emphasized the role of MHC class II
or class I–peptide antigen presentation systems. However,
the discovery of the CD1 antigen presentation system offers
an alternative and complementary mechanism by which
mycobacterial glycolipids specifically activate T cells (7).
Three human group 1 CD1 isoforms, CD1a, CD1b, and
CD1c, present mycobacterial lipids to T cells (8–11). The
structures of mycobacterial lipids presented by CD1b in-
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clude free mycolic acids, glucose monomycolate (GMM),
 
1
 
and phosphatidylinositol-containing lipoglycans such as li-
poarabinomannan, lipomannan, and phosphatidylinositol
mannoside (8, 12, 13). CD1c proteins present an unusual
fully saturated mycobacterial mannosyl phosphoisoprenoid
antigen that is related to eukaryotic dolichyl phosphogly-
colipids (14). These mycobacterial lipid antigens are immu-
nologically foreign because they have a mycolic acid, phos-
phatidylinositol mannoside, or isoprenoid core structure
that is unique to mycobacteria and related species, but not
found in mammalian cells. Furthermore, several of these
lipids are abundant structural components of the protective
mycobacterial cell wall and have been shown to influence
mycobacterial viability, making them attractive targets for
immune recognition in host defense (15, 16). CD1-
restricted, mycobacterial lipid–specific T cells possess effec-
tor mechanisms that promote clearance of mycobacterial
infections, including IFN-
 
g
 
 secretion, cytolysis, and granu-
lysin delivery (7, 17, 18). These observations suggest a
straightforward model for CD1 function in host defense
whereby pathogenic mycobacteria infect tissues, including
CD1
 
1
 
 dendritic cells that present foreign glycolipids to an-
tigen-specific T cells that contribute to bacterial clearance.
Although there is growing evidence that the general
mechanism of CD1-mediated glycolipid recognition in-
volves direct interactions of the TCR with a CD1–antigen
complex, detailed structural knowledge of the proposed
TCR ligands is not yet available, and the extent to which
such responses are specific for glycolipid antigen structure is
unknown (19, 20). T cell activation may require only that a
glycolipid be bound to a CD1 protein, as suggested by
studies of murine T cell hybridomas that responded to a se-
ries of antigens that differed substantially in the structure of
the hydrophilic elements (21). Alternatively, recognition
may be highly specific for the molecular structure of the
glycolipid, as suggested by a study of native T cell recogni-
tion of synthetic analogues of glycosylated mycolates and
 
a
 
-glycosyl ceramides (12, 22, 23).
Furthermore, the tissue expression of antigenic glycolip-
ids is almost completely unexplored, yet the proposed
functions of glycolipid-specific T cells require that their an-
tigens be expressed in target tissues in a form recognizable
by T cells. For example, CD1d-restricted T cells recognize
purified phosphatidylinositols and 
 
a
 
-glycosylceramides, yet
the former are self-lipids present ubiquitously in cells,
whereas the latter are synthetic or marine sponge–derived
compounds that are not known to exist at all in mammalian
cells (21, 22). Although mycobacteria-specific T cells have
been proposed to function by recognizing foreign lipids
and glycolipids within infected tissues, there is no informa-
tion regarding the generation or recognition of T cell
epitopes in infected tissues in vivo. T cell recognition of
mycobacterial GMM suggests that this glycolipid is a target
 
of the human immune response to mycobacteria (12).
However, it is not known whether GMM is even pro-
duced by infecting mycobacteria in vivo, and this molecule
is produced during in vitro growth only when exogenous
glucose is provided in the media (12, 24, 25). Thus, it is
not clear whether this CD1b-restricted T cell antigen is
produced during infection or whether it is an artifact of in
vitro growth conditions.
To address these questions, we undertook a detailed
study of T cell specificity for mycobacterial glycosylated
mycolates, including those produced during a tissue-based
mycobacterial infection. Our results show that T cell rec-
ognition of GMM was mediated by the TCR and was
highly specific for the precise structure of natural GMM
produced by mycobacteria, including the glucose moiety,
the linkage of glucose to the mycolate, and the stereo-
chemistry of the mycolate lipid. These results indicate that
T cells are capable of extremely precise discrimination of
the hydrophilic cap of the antigen that likely functions as a
classical TCR epitope by directly contacting TCR variable
regions. Importantly, mycobacteria growing extracellularly
were not capable of de novo GMM production, but myco-
bacteria produced antigenic GMM when grown in the
presence of exogenous glucose in vitro or within infected
mammalian tissues in vivo. Therefore, we propose that
during natural infections mycobacteria synthesize GMM by
capturing host glucose and esterifying it to mycobacterial
mycolates. Specific CD1b-mediated T cell recognition of
an antigen produced by the interaction of host and patho-
gen biosynthetic pathways provides a potential immune
mechanism for recognizing and responding only to those
mycobacteria that have productively infected host tissues.
 
Materials and Methods
 
Glycolipid Antigens. Mycobacterium leprae
 
 (Colorado State Uni-
versity, Fort Collins, CO) was harvested directly from the liver of
infected armadillos as described (26). 
 
Mycobacterium tuberculosis
 
H37Ra
 
 
 
(Colorado State University), 
 
Mycobacterium smegmatis
 
,
 
Mycobacterium avium
 
 serovar 4 (H. Remold, Brigham and
Women’s Hospital, Boston, MA), 
 
Mycobacterium phlei
 
 (American
Type Culture Collection), and
 
 Rhodococcus equi
 
 (American Type
Culture Collection) were cultured in standard medium (7H9
[Difco]; 0.5 g/liter Tween 80 [Fisher Scientific]) supplemented
with 10 g/liter 
 
d
 
-glucose, 3-
 
O
 
-methyl glucose, fructose, man-
nose, galactose, 
 
l
 
-arabinose, 
 
d
 
-arabinose, sorbose, xylose, or glu-
cose (Sigma-Aldrich). Quantitative measurement of 
 
M. avium
 
GMM was accomplished by cultivation in standard medium that
was additionally supplemented with 0.5 g/liter BSA, 0.4 mg/liter
catalase (Sigma-Aldrich), and 10 g/liter glycerol followed by 2 d
of culture in the absence of glycerol, then by addition of glucose
at the indicated concentration and culture for 24 h at an optical
density typical of log phase growth (OD
 
600
 
 
 
5 
 
0.25–0.35).
Bacteria were washed with PBS, then deionized water, then
were lyophilized and extracted for 2 h at 7.5 mg/ml in chloro-
form/methanol (2:1) to give total extractable lipid. 
 
M. phlei
 
 and
 
R. equi
 
 GMM were purified using silica columns as described
(12). Preparative TLC of crude 
 
M. leprae
 
 lipids was carried out on
200-
 
m
 
m silica-coated glass TLC plates (Scientific Adsorbants In-
corporated) developed in chloroform/methanol/water (60:16:2).
 
1
 
Abbreviations used in this paper:
 
 GMM, glucose monomycolate; G-6-MM,
C
 
32
 
 glucose-6-
 
O
 
-monomycolate; G-3-MM, glucose-3-
 
O
 
-monomyco-
late; MAME, mycolic acid methyl ester; Myc PL, mycolylphospholipid;
NMR, nuclear magnetic resonance; 
 
R
 
f
 
, retardation factor. 
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Silica was scraped in 1-cm intervals and lipids were extracted with
three washes of chloroform/methanol (2:1). GMM yields were
estimated by silica TLC developed in chloroform/methanol (90:8)
and charred with cupric acetate solution at 160
 
8
 
C for 15 min fol-
lowed by computer-assisted densitometry (Scion Image Software)
with quantitative standards.
C
 
32
 
 glucose-6-
 
O
 
-monomycolate (G-6-MM) was synthesized
from 3-
 
tert
 
-butyldimethylsilylated mycolic acid and 1,2,3,4-tetra-
 
O
 
-
 
tert
 
-butyldimethylsilylated glucose as described (12, 27). Glu-
cose-3-
 
O
 
-monomycolate (G-3-MM) was synthesized using a
similar strategy except that 4,6-
 
O
 
-benzylidene-1,2-
 
O
 
-isopropyl-
idene derivative of glucose was used to couple via a 3-linkage.
Synthetic C
 
32
 
 mycolic acid was methylated and resolved in chlo-
roform on preparative silica TLC plates to yield the 2
 
R
 
, 3
 
R
 
 plus
2
 
S
 
, 3
 
S
 
 enantiomeric pair with a retardation factor (
 
R
 
f
 
) of 0.42,
and the 2
 
R
 
, 3
 
S
 
 plus 2
 
S
 
, 3
 
R
 
 enantiomeric pair with an 
 
R
 
f
 
 of 0.52,
as determined by previous reports and comparison with methyl
esters of the natural C
 
32
 
 2
 
R
 
, 3
 
R
 
 mycolate standard from 
 
R. equi
 
(27). These mycolic acid methyl esters were glucosylated as de-
scribed and used in T cell assays (27). To confirm that the gluco-
sylation reaction did not racemize the mycolic acids, GMMs were
resaponified, methylated, and resolved on analytical TLC as de-
scribed above.
 
M. tuberculosis
 
 trehalose dimycolate, arabinomycolate, glycerol
mycolate, and mycolylphospholipid
 
 
 
(Myc PL) were purified as
described (12, 28). The
 
 M. avium
 
 hexose phosphoisoprenoid anti-
gen that stimulates the T cell line CD8-1 was partially purified
from 
 
M. avium 
 
as described (14). This organic phase was dried
under nitrogen, resuspended in chloroform, and loaded on an
open silica column that was sequentially eluted with chloroform,
acetone, and methanol as described (12). The mixture of metha-
nol-eluting lipids was weighed and used as a source of antigen.
The chemical identities of the pure lipid antigens were confirmed
using analytical TLC, electrospray ionization mass spectroscopy
(Quattro II triple quadrupole mass spectrometer; Micromass), and
nuclear magnetic resonance (NMR) (ACE 300; Bruker).
 
Cells.
 
LDN5, a TCR-
 
a
 
/
 
b
 
1
 
CD4
 
2
 
CD8
 
2
 
 T cell line, was iso-
lated from a skin biopsy specimen of a human subject with an
asymptomatic infection with 
 
M. leprae
 
 diagnosed on the basis of a
positive intradermal skin test and a clinical history of contact with
a leprosy patient (12). CD8-1, a TCR-
 
a
 
/
 
b
 
1
 
CD4
 
2
 
CD8
 
1
 
 T cell
line, was derived from the peripheral blood of a random donor
(10). CD1
 
1
 
 monocyte-derived dendritic cells were prepared from
random donor peripheral blood by centrifugation (670 
 
g
 
 for 15
min) over Ficoll-Hypaque, adherence to plastic tissue culture
flasks (Falcon), culture of adherent cells with 300 U/ml granulo-
cyte/monocyte-colony stimulating factor and 400 U/ml IL-4 for
72–96 h, followed by 
 
g
 
-irradiation (5,000 rads). T cells were cul-
tured at a 1:1 ratio with irradiated monocyte-derived dendritic
cells in 24-well plates in T cell media (RPMI 1640 supplemented
with 10% FCS [Hyclone], 
 
l
 
-glutamine, essential amino acids,
nonessential amino acids, 2-mercaptoethanol [GIBCO BRL],
and 1 nM recombinant human IL-2 [Ajinomoto]). T cell lines
were restimulated every 14–28 d with fresh irradiated monocyte-
derived dendritic cells and T cell media containing 5 
 
m
 
g/ml of
 
M. tuberculosis
 
 or 
 
M. phlei
 
 sonicate. C1R lymphoblastoid cells
transfected with the vector pSR
 
a
 
-NEO containing the cDNAs
encoding human CD1a, CD1b, or CD1c were also used as APCs
in cellular assays to determine restriction (11).
 
TCR Transfections and Flow Cytometry.
 
Transfection methods
and sequences of TCR 
 
a
 
 and 
 
b
 
 chains from LDN5 (TCR-
AV3
 
S
 
1J9C1, TCRBV7S1D2J2
 
S
 
1C2) and CD8-1 (TCRAV-
3
 
S
 
1J17C1, TCRBV2
 
S
 
1D2
 
S
 
1J2
 
S
 
7C2) have been described pre-
 
viously (19, 29). In brief, RNA from 2 
 
3
 
 10
 
5
 
–2 
 
3
 
 10
 
6
 
 T cells
was mixed with carrier DNA from 10
 
6
 
 EBV-transformed B cells
and used to prepare oligo (dT)–primed double stranded cDNA
that was incubated with T4 polymerase to form blunt-ended
cDNA. This product was circularized with T4 DNA ligase and
used as a template for inverse PCR using C
 
a
 
- or C
 
b
 
-specific
primers oriented in the opposite directions. The amplified TCR
genes were cloned into pBluescript II (Stratagene) and sequenced
using the Sequenase v2.0 kit (United States Biochemical). These
sequences were used to design V
 
a
 
- and V
 
b
 
-specific primers for
the appropriate V genes. RNA isolated from T cells was used to
synthesize single stranded cDNA with Superscript II reverse tran-
scriptase (GIBCO BRL) and an oligo (dT) primer. This cDNA
was used for PCR amplification followed by digestion with the
appropriate endonucleases, gel purification, and ligation into
pREP 7 (
 
a
 
 chains) or pREP 9 (
 
b
 
 chains; both from Invitrogen)
expression vectors. These constructs were electrophoretically
transfected into TCR-deficient J.RT3-T3.5 (J.RT3) cells which
were subsequently maintained in media supplemented with G418
(1 mg/ml) and hygromycin B (0.5 mg/ml) for 2–4 wk. Transfec-
tants were evaluated for surface CD3 expression by staining with
20 
 
m
 
g/ml SPVT3b (anti-CD3e) at 48C in PBS/5% FCS at 106
cells per 50 ml, followed by 20 mg/ml FITC goat F(ab9)2 anti–
mouse IgG/IgM (Biosource International). Cells were washed
and resuspended in PBS/FCS and analyzed on a FACSort™ flow
cytometer (Becton Dickinson). Dead cells were excluded based
on forward and side scatter.
T Cell Activation Assays. T cell proliferation was measured by
incubating 5 3 104 T cells with antigen and 5 3 104 g-irradiated
(5,000 rads) monocyte-derived dendritic cells in 96-well microti-
ter plates for 3–4 d followed by addition of 1 mCi [3H]thymidine
(New England Nuclear) and an additional 6 h of culture before
harvesting and counting b emissions (Beta plate; Wallac) as de-
scribed (11). IL-2 release was measured by culture of 105 J.RT3
cells in the presence of either 10 ng/ml of PMA alone or 10 ng/
ml PMA with 5 3 104 monocyte-derived dendritic cells or C1R
lymphoblastoid APCs and antigen in 200 ml/well in 96-well mi-
crotiter plates. After 24 h, 25 ml of supernatant was transferred to
wells containing 75 ml of media and 5 3 103 IL-2–dependent
HT-2 cells and cultured for 24 h before adding 1 mCi [3H]thymi-
dine for an additional 6–24 h of culture, followed by harvesting
and counting b emissions. Assays were done in triplicate and re-
ported as the mean 6 SD except as indicated.
Results
Clonally Variable Segments of the TCR a and b Chains
Mediated CD1b-restricted Recognition of GMM. The  a/b
T cell line LDN5 was derived from the skin biopsy speci-
men of a human patient infected with M. leprae and had
been previously shown to recognize mycobacterial GMM
presented by CD1b1 APCs (12). To determine whether
the TCR mediated GMM recognition, the LDN5 TCR a
and b chains were cloned into mammalian expression vec-
tors and cotransfected into J.RT3 T lymphoblastoid cells
that expressed low levels of CD3 complexes due to a lack
of the endogenous TCR b chain (29, 30). Cotransfection
of the TCR a and b genes from LDN5 restored surface
expression of CD3 complexes to a high level and con-
ferred upon LDN5ab/J.RT3 cells the ability to secrete
IL-2 in response to GMM (Fig. 1). Recognition of GMM968 Generation of a Mycobacterial Glycolipid Antigen In Vivo
was seen only when B lymphoblastoid APCs were trans-
fected with CD1b but not when mock transfected or
transfected with other CD1 isoforms (Fig. 1 C). Thus, rec-
ognition of GMM required CD1b expression by the APCs
and expression of the TCR a and b chains by the re-
sponding T cells.
Since certain lipids can directly activate T cells via in-
variant components of the CD3 complex–related signaling
pathways (31–33), it was important to determine whether
TCR transfection conferred GMM recognition simply by
reconstituting functional CD3 complexes on J.RT3 cells or
also required the TCR variable regions unique to LDN5.
Therefore, J.RT3 cells were reconstituted with TCR a
and b chain pairs other than those from LDN5. Transfec-
tion of TCR a and b chains from the mannosyl phospho-
isoprenoid–specific T cell line CD8-1 (CD8-1ab/J.RT3)
did not confer GMM recognition, even though transfec-
tion of this TCR-a/b chain pair reconstituted CD3 com-
plexes that mediated IL-2 release in response to OKT3 or
the mannosyl phosphoisoprenoid antigen (14; Fig. 1 B). As
a further control, the TCR b chain from LDN5 was trans-
fected, allowing pairing with the endogenous JRT.3 TCR
a chain (LDN5b/J.RT3). LDN5b/J.RT3 also failed to
recognize GMM even though it expressed functional CD3
complexes as measured by OKT3 activation (Fig. 1 B).
These results demonstrated that reconstitution of functional
CD3 complexes on J.RT3 by TCR a and b chains other
than properly paired LDN5 TCR chains was not sufficient
to confer GMM recognition, and that variable regions of
the TCR unique to LDN5 were required.
Figure 1. Variable regions of the TCR a and b chains mediated
CD1b-restricted recognition of GMM. (A) CD3 expression by untrans-
fected J.RT3 cells and J.RT3 cells contransfected with the LDN5 TCR
a (TCRAV3S1J9C1) and b (TCRBV7S1D2S1J2S1C2) chains was de-
termined by FACS® with an anti-CD3e (SPV-T3b; open histogram)
compared with staining with a nonbinding isotype-matched control
mAb (P3; filled histogram). MFI, mean fluorescence intensity. (B) J.RT3
cells cotransfected with LDN5 TCR a and b chains, the CD8-1 TCR a
and b chains, or the LDN5 TCR b chain were assayed for IL-2 release
in response to stimulation by OKT3 (20 mg/ml), M. phlei GMM (13 mg/
ml), or the mycobacterial phospholipid containing the mannosyl phos-
phoisoprenoid antigen (PL; 1 mg/ml) presented by monocyte-derived
dendritic cells. IL-2 release was quantified by measuring proliferative re-
sponses of IL-2–responsive HT-2 cells cultured with J.RT3 supernatants.
(C) LDN5ab/J.RT3 cells were assayed for IL-2 release when stimulated by GMM (5 mg/ml) presented by C1R B lymphoblastoid cells transfected
with vector alone (mock) or cDNAs encoding either CD1a, CD1b, or CD1c.969 Moody et al.
The TCR-mediated Antigen Recognition Was Specific for the
Carbohydrate Structure of Naturally Occurring Glycosylated My-
colates. Mycobacteria synthesize a variety of natural gly-
cosylated mycolates that are related in structure to GMM.
These include free mycolic acids and mycolic acids esteri-
fied to carbohydrates including glycerol, arabinose, treha-
lose, and Myc PL (28, 34–36; Fig. 2). CD1b presents free
mycolic acids to several human T cell lines, indicating that
the unglycosylated mycolic acid structure alone is sufficient
for uptake and presentation by APCs and recognition by
certain T cells (8, 12, 37). Since all glycosylated mycolates
contain the mycolate moiety, any of these natural glyco-
sylated mycolates might be expected to bind CD1b and be
presented to T cells. Therefore, the specificity of LDN5
and LDN5ab/J.RT3 were evaluated by testing them
against a panel of natural glycosylated mycolates produced
by mycobacteria. This revealed that LDN5 responded only
to GMM, except for slight cross-reactivity for arabinomy-
colate (Fig. 2). Even antigens such as trehalose monomy-
colate and trehalose dimycolate that possessed GMM as a
substructure failed to stimulate LDN5, indicating that
monocyte-derived dendritic cells did not cleave these
larger natural glycolipids to generate GMM that could be
efficiently presented to T cells (Fig. 2). This pattern of rec-
ognition of natural glycosylated mycolates extended the
results of a previous study (12), demonstrating that T cell
recognition required the glucose moiety, was specific for
the structure of the glucose moiety, and was not permissive
of a second glycosyl residue at the anomeric carbon of glu-
cose.
Figure 2. LDN5 and LDN5ab/J.RT3 cells recognized GMM but not other naturally occurring mycobacterial glycosylated mycolates. Glucose-6-O-
monomycolate, free mycolate, glycerol mycolate, arabinose-5-O-monomycolate, trehalose-6-O-monomycolate, Myc PL, and trehalose dimycolate
(cord factor) were purified from mycobacteria and cultured with monocyte-derived dendritic cells for presentation to LDN5 and LDN5ab/J.RT-3. R
indicates the meromycolate R group which, if present, may be a keto, wax ester, or methoxy derivative. M. tb, M. tuberculosis.
Figure 3. LDN5 and LDN5ab/
J.RT3 recognition of synthetic
GMM was specific for the 6-link-
age. G-3-MM and G-6-MM
were synthesized and the struc-
tures were confirmed by electro-
spray ionization mass spectros-
copy and NMR analysis.
Antigens (ag) were presented by
monocyte-derived dendritic cells
and responses were determined
by proliferation for LDN5 and
by HT-2 assay of IL-2 release for
LDN5ab/J.RT3.970 Generation of a Mycobacterial Glycolipid Antigen In Vivo
Figure 4. LDN5 and LDN5ab/J.RT-3 cells specifically recognized the
2R, 3R stereochemical structure of the mycolic acid moiety of GMM. (A)
Free C32 mycolates produced synthetically by condensation of palmitate
were methylated and resolved with preparative silica TLC in chloroform
into two pairs of enantiomers, 2R, 3R plus 2S, 3S (Rf 0.42) and 2R, 3S
plus 2S, 3R (Rf 0.52), and then separately glucosylated to yield GMM. To
check the purity of the fraction containing 2R, 3S plus 2S, 3R GMMs and
to rule out racemization during the glucosylation reaction, GMMs were
cleaved with acid to yield free mycolates, methylated to yield mycolic acid
methyl esters (MAMEs) and resolved on silica TLC plates in chloroform.
Left lane, MAMEs from the mixture of all four synthetic GMM stereoiso-
mers; middle lane, MAME from 2R, 3R R. equi GMM; right lane, MAMEs
from preparative TLC-purified mixture of 2R, 3S plus 2S, 3R GMMs.
The lack of MAMEs from the mixture of 2R, 3S and 2S, 3R GMMs mi-
grating at Rf 0.42 indicated that this preparation was pure and that mycolic
acids were not racemized during the glucosylation reaction. (B) The pro-
liferative response of LDN5 and the IL-2 secretion of LDN5ab/J.RT3 in
response to stereoisomers of GMM containing C32 mycolates presented by monocyte-derived dendritic cells is shown. These results were typical of three
experiments. (C) Structural relationship of natural (2R, 3R) mycolate composed of C (gray), H (light gray), and O (black) with synthetic analogues that are
not known to occur naturally is depicted with truncated meromycolate and a branches. The synthetic 2S, 3R mycolate form differed from natural 2R, 3R
mycolate in the absolute orientation of the a and meromycolate branches at C2 as indicated by the arrow. The 2R, 3S form differed from the natural my-
colate in the absolute orientation of the 3-hydroxyl with regard to the meromycolate chain.
The TCR-mediated Antigen Recognition Was Specific for
Linkage and Stereochemistry of the Lipid Portion of Natural
GMM. To determine whether the fine specificity of
LDN5 was limited to the glucose moiety or also extended
to the hydrophilic elements of the mycolate lipid, we pro-
duced synthetic analogues of GMM that differed from natu-
ral glucose-6-O-(2R, 3R) monomycolate in the linkage or
the structure of the lipid. Natural mycobacterial GMM has
been previously shown to be composed of d-glucose esteri-
fied via the sixth carbon to mycolic acid (38), and NMR
analysis of the GMM used in this study confirmed the
6-linkage (data not shown). This naturally occurring 6-link-
age was required for LDN5 and LDN5ab/J.RT3 recogni-
tion of GMM, as both lines recognized synthetic G-6-MM
but not an isomer linked via the third carbon of glucose,
G-3-MM (Fig. 3). This result provided evidence against a
nonspecific function of the glucose moiety such as facilitating
mycolate solubility, and was most consistent with the gener-
ation of an antigenic epitope formed by the glucose and the
adjacent hydrophilic elements of the mycolic acid (39).
The mycolate portion of the antigen is produced in vivo
by a stereospecific enzymatic condensation of free fatty ac-
ids to yield an a-branched, 3-hydroxy fatty acid with an R
configuration at the two chiral carbons, C2 and C3 (40–43).
This 2R, 3R conformation is structurally important for nat-
ural mycolates because it allows the hydroxyl group of the
mycolate to form a hydrogen bond with the carbonyl func-
tion, forming a ring structure that restricts rotation at C1,
C2, and C3 of the mycolate (44). In contrast, the chemical
synthesis of mycolates yielded this isomer as well as three971 Moody et al.
stereoisomers that are not known to occur naturally (2R,
3S; 2S, 3S; and 2S, 3R) (Fig. 4, A and C). Therefore, we
asked whether LDN5 might also possess specificity for the
mycolic acid portion of GMM by assaying for recognition
of short chain G-6-MMs that differed only in the stereo-
conformation at C2 and C3 of the lipid. LDN5 recognized
natural 2R, 3R GMM from R. equi and also responded at a
somewhat higher dose to a mixture of synthetic GMMs
containing all four stereoisomers (Fig. 4 B). However, both
the native T cell line and the TCR transfectants failed to
recognize a mixture of (2R, 3S) and (2S, 3R) GMMs, indi-
cating that both the absolute orientation of the lipid
branches and the stereoconfiguration of the 3-hydroxyl
group found in natural mycobacterial GMM were required
for recognition (Fig. 4 C). These results established that the
LDN5 TCR–mediated recognition of GMM was highly
specific for the hydrophilic portions of the lipid adjacent to
the carbohydrate and the linkage of the lipid to the carbo-
hydrate. Moreover, in all cases LDN5 recognized only the
synthetic GMMs that recapitulated the hydrophilic struc-
ture of the natural from of GMM produced by mycobacte-
ria, glucose-6-O-(2R, 3R) monomycolate.
Mycobacterial Synthesis of Antigenic GMM In Vitro and In
Vivo Required an Exogenous Source of Glucose. This precise
specificity for the structure of natural mycobacterial GMM
suggested that this glycolipid functioned as a target of the
human T cell response to mycobacterial infection. How-
ever, despite the isolation of GMM from mycobacteria
grown in vitro by several groups, it has not been clearly es-
tablished that infecting mycobacteria growing in vivo pro-
duce GMM (24, 25, 38). Furthermore, although mycobac-
teria grown in glucose-supplemented media synthesized
large amounts of GMM, GMM has not generally been re-
covered from mycobacteria grown in glucose-free media,
suggesting that GMM production may even be an artifact
of in vitro growth (24, 25).
Since glucose is an abundant metabolite in mammalian
cells and tissues and is homeostatically controlled to remain
at concentrations near 100 mg/dl (z6 mM), we reasoned
that mycobacteria might utilize host glucose for production
of GMM within infected tissues in vivo. Therefore, we first
sought to determine whether exogenous glucose was nec-
essary for production of antigenic GMM in vitro. M. phlei
and M. smegmatis were cultured in standard media supple-
Figure 5. Mycobacterial production of antigenic
GMM required exogenous glucose. (A) M. phlei
and M. smegmatis were grown in standard (7H9;
GIBCO BRL) medium that was supplemented
with 1 g/dl d-glucose or the indicated carbohy-
drate. Mycobacteria were washed, lyophilized, and
then extracted at 7.5 mg/ml with chloroform/
methanol to give the total lipid fraction (dilution 5
1). LDN5 proliferation in response to total lipid
fractions presented by monocyte-derived dendritic
cells is shown as the mean of duplicate samples
with error bars indicating the range. (B) M. avium
was cultured in medium supplemented with glu-
cose at the indicated concentration for 24 h. Total
extractable lipids were weighed and tested for their
ability to stimulate IL-2 secretion by LDN5ab/
J.RT3 cells. The relative yield of mycobacteria af-
ter culture for 24 h with each of the indicated glu-
coses was estimated by the optical density of the
culture fluid at 600 nm (OD600). Computer-assisted,
densitometric charring of total lipids resolved by
TLC indicated that GMM comprised z1 mg/mg
of total lipid from mycobacteria grown at 100 mg/dl
(data not shown).972 Generation of a Mycobacterial Glycolipid Antigen In Vivo
mented either with d-glucose or structurally related sugars
that are not present or are present only in trace amounts in
mammalian cells. Total lipid extracts from bacteria grown
in different conditions were tested for their ability to stimu-
late the GMM-specific T cell response of LDN5. Both M.
phlei and M. smegmatis grown in glucose-supplemented me-
dia produced GMM abundantly as detected by TLC (data
not shown), and total lipids from these mycobacteria po-
tently stimulated the LDN5 response (Fig. 5 A). In con-
trast, mycobacteria grown in standard media supplemented
with a carbohydrate other than glucose failed to produce
GMM as detected by TLC (data not shown) and did not
stimulate LDN5 (Fig. 5 A). This confirmed previous re-
ports that GMM synthesis was dependent on exogenous
glucose and demonstrated that this upregulation of GMM
production can activate T cells in vitro. Next, we sought to
determine the dose dependence of GMM production on
exogenous glucose over a range of concentrations includ-
ing the 100 mg/dl concentration that is typical of mamma-
lian tissues. GMM production by M. avium was also depen-
dent on exogenous glucose, and GMM was produced in
media containing glucose in the range of concentrations
typical of mammalian tissues. GMM comprised z0.1% of
the total extractable lipid when growing at 100 mg/dl of
glucose, both as measured by the LDN5 bioassay and by
direct charring of TLC plates, making it the single most
abundant extractable glycolipid in M. avium grown in these
conditions (Fig. 5 B). Thus, several species of mycobacteria
did not detectably produce GMM de novo, but did pro-
duce this antigen in abundance when cultured with exoge-
nous glucose, including glucose concentrations available to
mycobacteria during tissue-based growth.
To determine whether mycobacteria would produce
GMM during growth within mammalian tissue in vivo, the
obligate intracellular parasite, M. leprae, was harvested di-
rectly from the liver of infected armadillos and tested for
stimulation of LDN5. Crude sonicates of M. leprae grown
in vivo stimulated LDN5 (data not shown), and extraction
of the crude sonicate with chloroform/methanol (2:1) re-
vealed that the antigen efficiently partitioned into the lipid-
containing phase. Separation of total M. leprae lipids by
preparative TLC indicated that the antigen was found in
glycolipid fractions and comigrated with an authentic
GMM standard (Fig. 6). Although the quantities of GMM
isolated directly from cells were not adequate for detailed
structural characterization, the comigration of the stimula-
tory glycolipid with a GMM standard and the precise spec-
ificity of LDN5 for the structure of GMM provide strong
evidence that M. leprae growing within tissues in vivo pro-
duced antigenic GMM.
Discussion
Self and foreign proteins are composed from essentially
the same amino acid pool. Therefore, T cell discrimination
of self from foreign proteins is accomplished by reading out
differences in primary amino acid sequences by highly spe-
cific TCR interactions with antigenic peptides lying within
the grooves of MHC class I and class II proteins (45–47).
Mammals and microbes differ fundamentally in certain lipid
and carbohydrate biosynthetic pathways, so self and foreign
glycolipids have certain fundamental differences in struc-
ture (19). Thus, T cell discrimination of self from foreign
glycolipids might be accomplished with a lesser degree of
specificity for antigen structure than seen for peptides, and
the few available studies of CD1-restricted T cells have
demonstrated varying degrees of antigen specificity (12, 22,
23, 31). In one case, an mCD1d-restricted murine T cell
hybridoma recognized phosphatidic acid antigens that dif-
fered substantially in their hydrophilic structure, phosphati-
dyl inositol, phosphatidyl glycerol, and phosphatidyl etha-
nolamine (21). This study provided a comprehensive
evaluation of the molecular determinants of recognition of
a naturally occurring bacterial glycolipid antigen, glucose
Figure 6. LDN5 recognized a GMM-comigrating lipid from M. leprae
isolated directly from infected tissue. M. leprae was harvested directly from
armadillo liver and total lipid was extracted with chloroform/methanol
(2:1), loaded on a preparative silica TLC plate, and developed in chloro-
form/methanol/water (60:16:2) compared with a GMM standard (10 mg)
purified from in vitro cultures of M. phlei. The TLC plate was scored at
1-cm intervals as indicated, and the lipids were separately extracted from
each 1-cm fraction using chloroform/methanol (2:1). Extracts from each
fraction were dried under nitrogen, resuspended in T cell medium (1:5
dilution) with monocyte-derived dendritic cells, and tested for stimula-
tion of LDN5. The margin of the preparative plate was reserved and de-
veloped by charring with a cupric acetate solution and shown in compar-
ison with the M. phlei GMM standard.973 Moody et al.
monomycolate. The results indicated that T cell recogni-
tion can be extremely precise for glycolipid antigen struc-
ture, particularly the carbohydrate and adjacent elements of
the lipid that form the functional unit referred to as the hy-
drophilic cap (Fig. 7).
We and others have proposed that the molecular mecha-
nism of this specificity occurs by a trimolecular interaction
of the TCR with the hydrophilic cap of the antigen as it
protrudes from the CD1 groove (12, 19, 20). This study
strongly supports this mechanism by directly demonstrating
a functional requirement of the clonally variable elements
of the LDN5 TCR in mediating a pattern of fine specificity
for the hydrophilic elements of the antigen that are pro-
posed to protrude from the CD1 groove. The TCR-medi-
ated response to GMM was specific for all tested elements
of the hydrophilic cap, including substitutions of the ano-
meric carbon of the carbohydrate (Fig. 2), the linkage of
the carbohydrate to the mycolate lipid (Fig. 3), the absolute
orientation of the mycolate b-hydroxyl (Fig. 4), and the
absolute orientation of the two alkyl chains with regard to
the carbohydrate (Fig. 4). These data clearly establish that
both the carbohydrate and lipid components of GMM are
required for recognition by LDN5, most likely by direct
contact of TCR variable regions with the double ring
structure formed by the linkage of the mycolate to glucose
(Fig. 7).
The specificity of LDN5 for only those synthetic GMMs
that precisely recapitulate the structure of the hydrophilic
cap of natural mycobacterial glucose-6-O-(2R, 3R) mono-
mycolate suggests that this glycolipid is a relevant target of
the in vivo human T cell response to mycobacteria. We
have reported that phospholipid-specific polyclonal T cell
responses occur following mycobacterial infection (14).
Recently, we have found similar responses to GMM in
PBLs in the majority of subjects infected with M. tuberculo-
sis, but not naive controls, indicating that this antigen is a
target of the immune response during natural infections
(Ulrichs, T, unpublished data). Thus, GMM-specific T cell
activation is not just a property of LDN5, but is common
among polyclonal lymphocytes of humans infected with M.
Figure 7. The map of the an-
tigenic determinants of the
TCR-mediated response to nat-
ural glucose-6-O-(2R, 3R)
monomycolate. The hydro-
philic cap of GMM is formed
from host-derived glucose esteri-
fied via the sixth carbon to my-
cobacterial mycolate. Recogni-
tion of GMM required TCR a
and  b chains with the variable
regions corresponding to LDN5,
CD1b expression on the APC,
and all tested elements of the
structure of the hydrophilic cap
of natural GMM, including
components supplied by the host
and by the mycobacteria. Natu-
ral or synthetic analogues lacking
the indicated chemical element
(red) or proper stereoconfigura-
tion (green) of glucose-6-O-
(2R, 3R) monomycolate were
not recognized by cells bearing
the LDN5 TCR a and b chains,
but analogues lacking the distal
elements of the mycolate alkyl
chains (gray) were recognized.
Substitution of the anomeric
carbon (blue) with a-linked glu-
cose (trehalose mycolate) or
a-linked glucose monomyco-
late (trehalose dimycolate) abol-
ished recognition.974 Generation of a Mycobacterial Glycolipid Antigen In Vivo
tuberculosis. The biological significance of this reactivity in
the context of mycobacterial infection derives from the ob-
servation that GMM is, strictly speaking, neither self nor
foreign, but instead a combination of a self-carbohydrate
and a foreign lipid that are coupled only after successful in-
fection of host tissues by mycobacteria.
Mycobacteria synthesize mycolates using a hybrid fatty
acid synthase mechanism that differs from the type I fatty
acid synthase mechanism found in eukaryotic cells (16).
Thus, the a-branched, b-hydroxy structure of mycolic ac-
ids is not found in eukaryotic fatty acids, making mycolic
acids inherently foreign in structure to the mammalian im-
mune system. The enzymatic activity leading to coupling of
mycolates to glucose has not been identified, but GMM is
synthesized by all mycobacterial species studied to date and
can be quite abundant in the cell wall, comprising up to 2%
of the total extractable lipid (12, 38, 48; and Moody D.B.,
unpublished data). The results of the current study con-
firmed that M. smegmatis, M. phlei, and M. avium cannot
synthesize GMM de novo, but all three species produce an-
tigenic GMM in abundance when exposed to glucose in
vitro. Moreover, the obligate intracellular pathogen M. lep-
rae produced GMM while growing within mammalian liver
in vivo (Fig. 6). These results indicate that mycobacteria ac-
quire exogenous glucose from the media or host tissues and
esterify host glucose to mycobacterial mycolic acids.
Since glucose is not generally found in abundance in
mycobacterial growth environments other than infected
host tissues, we propose that expression of the GMM anti-
gen in nature is generally restricted to pathogenic myco-
bacteria that have invaded host tissues and would not be
expressed by saprophytic mycobacteria growing in the en-
vironment. This issue is particularly relevant for mycobac-
terial disease, since human exposure to environmental
saprophytes is common, but does not generally lead to de-
tectable cell-mediated immunity (49). Specific T cell rec-
ognition of a glycolipid antigen derived from the in vivo
coupling of host and pathogen factors could allow not only
discrimination of self from foreign structures, but also dis-
crimination of bacteria that have invaded tissue from bacte-
ria that have not. Many studies suggested that the host
avoids immunopathology by distinguishing foreign antigen
that is not a threat to the host (innocuous nonself) from
that which is a threat to the host (pathogenic nonself; for a
review, see reference 50). Thus, these results not only pro-
vide the first information about the expression of a CD1-
presented antigen in vivo within tissues, they also suggest a
new mechanism for discrimination of pathogenic from in-
nocuous nonself that would allow a vigorous response to
pathogenic mycobacteria while avoiding immunopathol-
ogy from casual exposure to innocuous saprophytes.
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